338 related articles for article (PubMed ID: 16544315)
41. PAX--FKHR fusion genes and AChR-gamma in Chinese patients with rhabdomyosarcoma: diagnosis using formalin-fixed archival tissues.
Chang B; Pang LJ; Qi Y; Liu CX; Cao Y; Li HA; Hu WH; Jiang JF; Zhang WJ; Li F
Int J Surg Pathol; 2009 Feb; 17(1):6-15. PubMed ID: 18988640
[TBL] [Abstract][Full Text] [Related]
42. Sinonasal rhabdomyosarcoma in children and young adults.
Ahmed AA; Tsokos M
Int J Surg Pathol; 2007 Apr; 15(2):160-5. PubMed ID: 17478770
[TBL] [Abstract][Full Text] [Related]
43. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.
Sebire NJ; Malone M
J Clin Pathol; 2003 Jun; 56(6):412-6. PubMed ID: 12783965
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
[TBL] [Abstract][Full Text] [Related]
45. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma.
Nishio J; Althof PA; Bailey JM; Zhou M; Neff JR; Barr FG; Parham DM; Teot L; Qualman SJ; Bridge JA
Lab Invest; 2006 Jun; 86(6):547-56. PubMed ID: 16607381
[TBL] [Abstract][Full Text] [Related]
46. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions.
Collins MH; Zhao H; Womer RB; Barr FG
Med Pediatr Oncol; 2001 Aug; 37(2):83-9. PubMed ID: 11496344
[TBL] [Abstract][Full Text] [Related]
47. [Alveolar rhabdomyosarcoma of unknown origin mimicking acute leukemia at the initial presentation].
Yamaguchi K; Koga Y; Suminoe A; Saito Y; Matsuzaki A; Kanno S; Takimoto T; Suda M; Oda Y; Muto T; Takatsuki H; Hara T
Rinsho Ketsueki; 2007 Apr; 48(4):315-20. PubMed ID: 17515123
[TBL] [Abstract][Full Text] [Related]
48. [Diagnosis of micrometastases of alveolar rhabdomyosarcoma].
Blizniukov OP; Petrovichev NN; Perevoshchikov AG; Poliakov VG
Arkh Patol; 2008; 70(2):36-40. PubMed ID: 18540440
[TBL] [Abstract][Full Text] [Related]
49. Embryonal and alveolar rhabdomyosarcoma of parameningeal sites in adults: a report of 13 cases.
Montone KT; Barr FG; Zhang PJ; Feldman MD; LiVolsi VA
Int J Surg Pathol; 2009 Feb; 17(1):22-30. PubMed ID: 18945709
[TBL] [Abstract][Full Text] [Related]
50. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Thomson B; Hawkins D; Felgenhauer J; Radich J
Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
[TBL] [Abstract][Full Text] [Related]
51. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.
Kumar S; Perlman E; Harris CA; Raffeld M; Tsokos M
Mod Pathol; 2000 Sep; 13(9):988-93. PubMed ID: 11007039
[TBL] [Abstract][Full Text] [Related]
52. PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells.
Tiffin N; Williams RD; Shipley J; Pritchard-Jones K
Br J Cancer; 2003 Jul; 89(2):327-32. PubMed ID: 12865925
[TBL] [Abstract][Full Text] [Related]
53. A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
Gattenloehner S; Dockhorn-Dworniczak B; Leuschner I; Vincent A; Müller-Hermelink HK; Marx A
J Mol Diagn; 1999 Nov; 1(1):23-31. PubMed ID: 11272905
[TBL] [Abstract][Full Text] [Related]
54. Classification of rhabdomyosarcoma and its molecular basis.
Parham DM; Barr FG
Adv Anat Pathol; 2013 Nov; 20(6):387-97. PubMed ID: 24113309
[TBL] [Abstract][Full Text] [Related]
55. Polymerase chain reaction-based diagnosis of rhabdomyosarcomas: comparison of fetal type acetylcholine receptor subunits and myogenin.
Gattenlöhner S; Müller-Hermelink HK; Marx A
Diagn Mol Pathol; 1998 Jun; 7(3):129-34. PubMed ID: 9836066
[TBL] [Abstract][Full Text] [Related]
56. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.
Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Furihata M; Ohtsuki Y
Int J Oncol; 2000 Jul; 17(1):119-25. PubMed ID: 10853028
[TBL] [Abstract][Full Text] [Related]
57. Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
Ahn EH; Mercado GE; Laé M; Ladanyi M
Oncol Rep; 2013 Aug; 30(2):968-78. PubMed ID: 23733015
[TBL] [Abstract][Full Text] [Related]
58. Cytogenetic and molecular findings related to rhabdomyosarcoma. An analysis of seven cases.
Gil-Benso R; López-Ginés C; Carda C; López-Guerrero JA; Ferrer J; Pellín-Pérez A; Llombart-Bosch A
Cancer Genet Cytogenet; 2003 Jul; 144(2):125-33. PubMed ID: 12850375
[TBL] [Abstract][Full Text] [Related]
59. Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Takahira T; Takahashi Y; Tajiri T; Taguchi T; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2008 Oct; 134(10):1097-103. PubMed ID: 18386058
[TBL] [Abstract][Full Text] [Related]
60. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).
Smith LM; Anderson JR; Coffin CM
Med Pediatr Oncol; 2002 Jun; 38(6):398-404. PubMed ID: 11984800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]